Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

U.K. Targets 40% Reduction In Rx Medical Errors By 2005

Executive Summary

The U.K.'s National Health Service is aiming to reduce the country's rate of serious errors related to prescription drug use by 40% by the year 2005.

You may also be interested in...



Electronic Reporting In U.K. Expected To Detect Unexpected AEs Sooner

The U.K. expects electronic reporting to enable earlier detection of adverse events as a safety net for shorter approval times.

Electronic Reporting In U.K. Expected To Detect Unexpected AEs Sooner

The U.K. expects electronic reporting to enable earlier detection of adverse events as a safety net for shorter approval times.

Medical Error Mandatory Reporting System Recommended By IoM

A mandatory reporting system for medical errors and adverse events that result in death or serious harm should be required by Congress, the Institute of Medicine recommended in a report released Nov. 29.

Latest Headlines
See All
UsernamePublicRestriction

Register

PS036590

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel